Correlation Between AVROBIO and Virios Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AVROBIO and Virios Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVROBIO and Virios Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVROBIO and Virios Therapeutics Llc, you can compare the effects of market volatilities on AVROBIO and Virios Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVROBIO with a short position of Virios Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVROBIO and Virios Therapeutics.

Diversification Opportunities for AVROBIO and Virios Therapeutics

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between AVROBIO and Virios is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding AVROBIO and Virios Therapeutics Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virios Therapeutics Llc and AVROBIO is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVROBIO are associated (or correlated) with Virios Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virios Therapeutics Llc has no effect on the direction of AVROBIO i.e., AVROBIO and Virios Therapeutics go up and down completely randomly.

Pair Corralation between AVROBIO and Virios Therapeutics

Given the investment horizon of 90 days AVROBIO is expected to generate 0.43 times more return on investment than Virios Therapeutics. However, AVROBIO is 2.33 times less risky than Virios Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Virios Therapeutics Llc is currently generating about -0.03 per unit of risk. If you would invest  117.00  in AVROBIO on September 2, 2024 and sell it today you would earn a total of  23.00  from holding AVROBIO or generate 19.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy75.29%
ValuesDaily Returns

AVROBIO  vs.  Virios Therapeutics Llc

 Performance 
       Timeline  
AVROBIO 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Virios Therapeutics Llc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virios Therapeutics Llc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly uncertain basic indicators, Virios Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

AVROBIO and Virios Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AVROBIO and Virios Therapeutics

The main advantage of trading using opposite AVROBIO and Virios Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVROBIO position performs unexpectedly, Virios Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virios Therapeutics will offset losses from the drop in Virios Therapeutics' long position.
The idea behind AVROBIO and Virios Therapeutics Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing